MAMLD1 and 46,XY disorders of sex development

Area of Science:

• Genetics and Molecular Biology
• Endocrinology
• Developmental Biology

Background:

• Mastermind-like domain containing 1 (MAMLD1) is a recently identified gene linked to 46,XY disorders of sex development (DSD).
• Hypospadias is the primary clinical feature observed in individuals with MAMLD1-related DSD.
• Previous studies identified microdeletions and mutations in MAMLD1 in affected patients, suggesting its critical role in male sexual differentiation.

Purpose of the Study:

• To investigate the functional role of MAMLD1 in fetal testosterone production and its contribution to 46,XY DSD.
• To elucidate the molecular mechanisms by which MAMLD1 mutations lead to compromised testosterone synthesis.

Main Methods:

• Analysis of MAMLD1 gene mutations and microdeletions in patients with 46,XY DSD.
• In vitro studies using mouse models to assess MAMLD1 expression patterns during fetal development.
• Functional assays involving Mamld1 knockdown in murine Leydig cells to evaluate testosterone production and gene expression (e.g., Cyp17a1).
• Investigation of MAMLD1 localization, transcriptional activity, and regulation by steroidogenic factor 1 (SF1).

Main Results:

• MAMLD1 is expressed in fetal Sertoli and Leydig cells during the critical period of sex development.
• Transient Mamld1 knockdown significantly reduced testosterone production, primarily due to impaired 17α-hydroxylation and reduced Cyp17a1 expression.
• MAMLD1 functions in the nucleus, transactivating target genes without direct DNA binding, and is regulated by SF1.

Conclusions:

• MAMLD1 mutations cause 46,XY DSD by disrupting fetal testosterone production during a critical developmental window.
• The findings implicate MAMLD1 in the molecular network regulating fetal testosterone synthesis, providing insights into DSD pathogenesis.
• Further research on MAMLD1's role can enhance understanding of the molecular mechanisms underlying male sexual development.